Nested Therapeutics, a Versant Ventures-backed biotech creating a next-gen precision medicine platform to focus on hard-to-treat cancers, announced the close of a $90 million Series A financing round ...

Just ask anyone, anywhere, ever, and they'll tell you: Buying and selling homes is a risky business. But help's supposedly on the way, in the form of yet another attempt at disrupting a business ...

Understanding the role of certain proteins and mutations has paved the way for many cancer therapies, but in some cases knowing the target and its role is not enough for scientists to be able to find ...